User Defined ID	Accession	Visit	Study Identifier	Study Part	Cohort Group	Treatment	Date of Informed Consent	Date of Screening Visit	Day of Screening	Date of T1DM Diagnosis	Day of Diagnosis of T1DM	Day 0 Date	Enrolled	Enrollment Date	Safety Sample	Intent to Treat Sample	Analysis Sample	Date of First Low Dose Infusion	Date of First High Dose Infusion	Date of Last Low Dose Infusion	Date of Last High Dose Infusion	Date of Last Follow-up	Date of Primary Endpoint Visit	Day of Last Follow-up	Completed Study (including follow-up)	Study Status	Current Study Phase	Date of Study Termination/Completion	Day of Study Termination	Terminated Study Reason	Other AE causing Termination	Date of Prot Dev causing Termination	Date of Other AE causing Termination	Completed Study Drug	Number of Low Dose Infusions	Number of High Dose Infusions	Date of Study Drug Discont./Completion	Day of Study Drug Discont./Completion	Discontinued Therapy Reason	Age (years)	Sex (Char)	Baseline Height (cm)	Baseline Weight (kg)	Baseline BMI (kg/m^2)	Race	Race.1	Ethnicity	Status	Termination since Last report	Disc. from Therapy since Last report	Completion since Last Report	Phase	Sequence Number	Visit Number	Visit_orig	C-peptide Test Date	C-peptide Study Day	Number of Non-missing Timepoints- 2 hr	Number of Non-missing Timepoints- 4 hr	2 Hour AUC	Baseline 2 Hour AUC	Log 2 Hour AUC	Baseline 2 Hour Log AUC	2 Hour AUC Change from Baseline	2 Hour Log AUC Change from Baseline	4 Hour AUC	Baseline 4 Hour AUC	Log 4 Hour AUC	Baseline Log 4 Hour AUC	4 Hour AUC Change from Baseline	4 Hour Log AUC Change from Baseline	2 Hr, Peak C-peptide	2 Hr. Peak C-peptide Time	4 Hr. Peak C-peptide	4 Hr. Peak C-peptide Time	Data Snapshot Date
RETAIN_135342	SUB228868	Visit -1 (Week -1)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-04-17	2010-04-18	-16.0	2010-03-31	-34.0	2010-05-04	Yes	2010-05-04	Yes	Yes	E/I/S	2010-05-04	2010-07-06	2010-06-08	2010-08-10	2012-04-29	2011-05-01	726.0	Yes	Complete		2012-04-29	726.0					Yes	6.0	6.0	2010-08-10	98.0		16.0	Female	168.9	69.2	24.26	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2010-04-18	-16.0	6.0	10.0	1.006583623	1.006583623	0.696433586	0.696433586			0.94236604	0.94236604	0.663906838	0.663906838			1.39	58.0	1.39	58.0	2014-06-06
RETAIN_135342	SUB228868	Visit 14 (Week 8)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-04-17	2010-04-18	-16.0	2010-03-31	-34.0	2010-05-04	Yes	2010-05-04	Yes	Yes	E/I/S	2010-05-04	2010-07-06	2010-06-08	2010-08-10	2012-04-29	2011-05-01	726.0	Yes	Complete		2012-04-29	726.0					Yes	6.0	6.0	2010-08-10	98.0		16.0	Female	168.9	69.2	24.26	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2010-08-31	119.0	6.0	6.0	0.91149125	1.006583623	0.647883697	0.696433586	-0.095092373	-0.048549889		0.94236604		0.663906838			1.05	60.0	1.05	60.0	2014-06-06
RETAIN_135342	SUB228868	Visit 15 (Week 19)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-04-17	2010-04-18	-16.0	2010-03-31	-34.0	2010-05-04	Yes	2010-05-04	Yes	Yes	E/I/S	2010-05-04	2010-07-06	2010-06-08	2010-08-10	2012-04-29	2011-05-01	726.0	Yes	Complete		2012-04-29	726.0					Yes	6.0	6.0	2010-08-10	98.0		16.0	Female	168.9	69.2	24.26	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2010-11-14	194.0	6.0	6.0	1.25159375	1.006583623	0.811638299	0.696433586	0.245010127	0.115204713		0.94236604		0.663906838			1.81	60.0	1.81	60.0	2014-06-06
RETAIN_135342	SUB228868	Visit 17 (Week 52)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-04-17	2010-04-18	-16.0	2010-03-31	-34.0	2010-05-04	Yes	2010-05-04	Yes	Yes	E/I/S	2010-05-04	2010-07-06	2010-06-08	2010-08-10	2012-04-29	2011-05-01	726.0	Yes	Complete		2012-04-29	726.0					Yes	6.0	6.0	2010-08-10	98.0		16.0	Female	168.9	69.2	24.26	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2011-05-01	362.0	6.0	10.0	1.387780084	1.006583623	0.870364099	0.696433586	0.381196461	0.173930513	1.133474184	0.94236604	0.757751723	0.663906838	0.191108144	0.093844885	1.76	89.0	1.76	89.0	2014-06-06
RETAIN_135342	SUB228868	Visit 21 (Week 104)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-04-17	2010-04-18	-16.0	2010-03-31	-34.0	2010-05-04	Yes	2010-05-04	Yes	Yes	E/I/S	2010-05-04	2010-07-06	2010-06-08	2010-08-10	2012-04-29	2011-05-01	726.0	Yes	Complete		2012-04-29	726.0					Yes	6.0	6.0	2010-08-10	98.0		16.0	Female	168.9	69.2	24.26	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2012-04-29	726.0	6.0	10.0	0.866328846	1.006583623	0.623973317	0.696433586	-0.140254777	-0.072460268	0.939474367	0.94236604	0.662416992	0.663906838	-0.002891673	-0.001489847	1.13	117.0	1.24	147.0	2014-06-06
RETAIN_143437	SUB228869	Visit -1 (Week -1)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-01-22	2011-01-28	-26.0	2010-11-18	-97.0	2011-02-23	Yes	2011-02-23	Yes	Yes	E/I/S	2011-02-23	2011-05-11	2011-03-30	2011-06-15	2013-02-21	2012-02-16	729.0	Yes	Complete		2013-02-21	729.0					Yes	6.0	6.0	2011-06-15	112.0		9.0	Female	137.5	35.7	18.88	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2011-01-28	-26.0	6.0	10.0	0.559918487	0.559918487	0.444633568	0.444633568			0.734570711	0.734570711	0.550759954	0.550759954			0.75	119.0	1.02	149.0	2014-06-06
RETAIN_143437	SUB228869	Visit 14 (Week 8)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-01-22	2011-01-28	-26.0	2010-11-18	-97.0	2011-02-23	Yes	2011-02-23	Yes	Yes	E/I/S	2011-02-23	2011-05-11	2011-03-30	2011-06-15	2013-02-21	2012-02-16	729.0	Yes	Complete		2013-02-21	729.0					Yes	6.0	6.0	2011-06-15	112.0		9.0	Female	137.5	35.7	18.88	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2011-07-06	133.0	6.0	6.0	0.410565168	0.559918487	0.343990453	0.444633568	-0.149353319	-0.100643116		0.734570711		0.550759954			0.5	59.0	0.5	59.0	2014-06-06
RETAIN_143437	SUB228869	Visit 15 (Week 19)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-01-22	2011-01-28	-26.0	2010-11-18	-97.0	2011-02-23	Yes	2011-02-23	Yes	Yes	E/I/S	2011-02-23	2011-05-11	2011-03-30	2011-06-15	2013-02-21	2012-02-16	729.0	Yes	Complete		2013-02-21	729.0					Yes	6.0	6.0	2011-06-15	112.0		9.0	Female	137.5	35.7	18.88	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2011-09-28	217.0	6.0	6.0	0.186514328	0.559918487	0.171019872	0.444633568	-0.37340416	-0.273613696		0.734570711		0.550759954			0.23	59.0	0.23	59.0	2014-06-06
RETAIN_143437	SUB228869	Visit 17 (Week 52)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-01-22	2011-01-28	-26.0	2010-11-18	-97.0	2011-02-23	Yes	2011-02-23	Yes	Yes	E/I/S	2011-02-23	2011-05-11	2011-03-30	2011-06-15	2013-02-21	2012-02-16	729.0	Yes	Complete		2013-02-21	729.0					Yes	6.0	6.0	2011-06-15	112.0		9.0	Female	137.5	35.7	18.88	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2012-02-16	358.0	6.0	10.0	0.137067949	0.559918487	0.128452974	0.444633568	-0.422850539	-0.316180594	0.140570253	0.734570711	0.131528359	0.550759954	-0.594000458	-0.419231595	0.16	57.0	0.17	177.0	2014-06-06
RETAIN_143437	SUB228869	Visit 21 (Week 104)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-01-22	2011-01-28	-26.0	2010-11-18	-97.0	2011-02-23	Yes	2011-02-23	Yes	Yes	E/I/S	2011-02-23	2011-05-11	2011-03-30	2011-06-15	2013-02-21	2012-02-16	729.0	Yes	Complete		2013-02-21	729.0					Yes	6.0	6.0	2011-06-15	112.0		9.0	Female	137.5	35.7	18.88	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2013-03-03	739.0	6.0	10.0	0.042188475	0.559918487	0.041322805	0.444633568	-0.517730013	-0.403310764	0.039692185	0.734570711	0.038924693	0.550759954	-0.694878526	-0.511835261	0.06	58.0	0.06	58.0	2014-06-06
RETAIN_168164	SUB228870	Visit -1 (Week -1)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-03-01	2011-03-01	-7.0	2010-12-20	-78.0	2011-03-08	Yes	2011-03-08	Yes	Yes	E/I/S	2011-03-08	2011-05-12	2011-04-12	2011-06-16	2013-03-07	2012-02-28	730.0	Yes	Complete		2013-03-07	730.0					Yes	6.0	6.0	2011-06-16	100.0		11.0	Male	151.0	35.9	15.74	White	White	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2011-03-01	-7.0	6.0	10.0	0.184429063	0.184429063	0.169260855	0.169260855			0.232475781	0.232475781	0.209024977	0.209024977			0.32	120.0	0.32	120.0	2014-06-06
RETAIN_168164	SUB228870	Visit 14 (Week 8)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-03-01	2011-03-01	-7.0	2010-12-20	-78.0	2011-03-08	Yes	2011-03-08	Yes	Yes	E/I/S	2011-03-08	2011-05-12	2011-04-12	2011-06-16	2013-03-07	2012-02-28	730.0	Yes	Complete		2013-03-07	730.0					Yes	6.0	6.0	2011-06-16	100.0		11.0	Male	151.0	35.9	15.74	White	White	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2011-07-06	120.0	6.0	6.0	0.196937866	0.184429063	0.179766517	0.169260855	0.012508804	0.010505663		0.232475781		0.209024977			0.29	116.0	0.29	116.0	2014-06-06
RETAIN_168164	SUB228870	Visit 15 (Week 19)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-03-01	2011-03-01	-7.0	2010-12-20	-78.0	2011-03-08	Yes	2011-03-08	Yes	Yes	E/I/S	2011-03-08	2011-05-12	2011-04-12	2011-06-16	2013-03-07	2012-02-28	730.0	Yes	Complete		2013-03-07	730.0					Yes	6.0	6.0	2011-06-16	100.0		11.0	Male	151.0	35.9	15.74	White	White	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2011-09-20	196.0	6.0	6.0	0.19357937	0.184429063	0.176956666	0.169260855	0.009150307	0.007695812		0.232475781		0.209024977			0.21	59.0	0.21	59.0	2014-06-06
RETAIN_168164	SUB228870	Visit 17 (Week 52)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-03-01	2011-03-01	-7.0	2010-12-20	-78.0	2011-03-08	Yes	2011-03-08	Yes	Yes	E/I/S	2011-03-08	2011-05-12	2011-04-12	2011-06-16	2013-03-07	2012-02-28	730.0	Yes	Complete		2013-03-07	730.0					Yes	6.0	6.0	2011-06-16	100.0		11.0	Male	151.0	35.9	15.74	White	White	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2012-02-28	357.0	6.0	10.0	0.17667125	0.184429063	0.162689478	0.169260855	-0.007757813	-0.006571377	0.195910625	0.232475781	0.178907925	0.209024977	-0.036565156	-0.030117052	0.27	90.0	0.27	90.0	2014-06-06
RETAIN_168164	SUB228870	Visit 21 (Week 104)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-03-01	2011-03-01	-7.0	2010-12-20	-78.0	2011-03-08	Yes	2011-03-08	Yes	Yes	E/I/S	2011-03-08	2011-05-12	2011-04-12	2011-06-16	2013-03-07	2012-02-28	730.0	Yes	Complete		2013-03-07	730.0					Yes	6.0	6.0	2011-06-16	100.0		11.0	Male	151.0	35.9	15.74	White	White	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2013-03-07	730.0	6.0	10.0	0.090102541	0.184429063	0.086271766	0.169260855	-0.094326522	-0.082989089	0.092969625	0.232475781	0.088898418	0.209024977	-0.139506156	-0.120126558	0.12	122.0	0.12	122.0	2014-06-06
RETAIN_192151	SUB228871	Visit -1 (Week -1)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-12-30	2010-12-30	-15.0	2010-10-10	-96.0	2011-01-14	Yes	2011-01-14	Yes	Yes	E/I/S	2011-01-14		2011-01-21		2013-01-11	2012-01-11	728.0	Yes	Complete		2013-01-11	728.0					No	2.0	0.0	2011-01-21	7.0	Investigator Decision	16.0	Male		72.0	23.78	Black or African American	Black or African American	Not Hispanic or Latino	Completed study, Discontinued therapy				1000	0	PIV-1	Visit -1/Week -1	2010-12-30	-15.0	6.0	10.0	0.52650587	0.52650587	0.422981378	0.422981378			0.458364575	0.458364575	0.377315653	0.377315653			0.66	85.0	0.66	85.0	2014-06-06
RETAIN_192151	SUB228871	Visit 14 (Week 8)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-12-30	2010-12-30	-15.0	2010-10-10	-96.0	2011-01-14	Yes	2011-01-14	Yes	Yes	E/I/S	2011-01-14		2011-01-21		2013-01-11	2012-01-11	728.0	Yes	Complete		2013-01-11	728.0					No	2.0	0.0	2011-01-21	7.0	Investigator Decision	16.0	Male		72.0	23.78	Black or African American	Black or African American	Not Hispanic or Latino	Completed study, Discontinued therapy				2014	0	PIV14	Visit 14/Week 8	2011-05-13	119.0	6.0	6.0	0.600189348	0.52650587	0.470121965	0.422981378	0.073683478	0.047140586		0.458364575		0.377315653			0.97	115.0	0.97	115.0	2014-06-06
RETAIN_192151	SUB228871	Visit 15 (Week 19)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-12-30	2010-12-30	-15.0	2010-10-10	-96.0	2011-01-14	Yes	2011-01-14	Yes	Yes	E/I/S	2011-01-14		2011-01-21		2013-01-11	2012-01-11	728.0	Yes	Complete		2013-01-11	728.0					No	2.0	0.0	2011-01-21	7.0	Investigator Decision	16.0	Male		72.0	23.78	Black or African American	Black or African American	Not Hispanic or Latino	Completed study, Discontinued therapy				2015	0	PIV15	Visit 15/Week 19	2011-07-29	196.0	6.0	6.0	0.692808462	0.52650587	0.526388961	0.422981378	0.166302592	0.103407583		0.458364575		0.377315653			0.89	117.0	0.89	117.0	2014-06-06
RETAIN_192151	SUB228871	Visit 17 (Week 52)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-12-30	2010-12-30	-15.0	2010-10-10	-96.0	2011-01-14	Yes	2011-01-14	Yes	Yes	E/I/S	2011-01-14		2011-01-21		2013-01-11	2012-01-11	728.0	Yes	Complete		2013-01-11	728.0					No	2.0	0.0	2011-01-21	7.0	Investigator Decision	16.0	Male		72.0	23.78	Black or African American	Black or African American	Not Hispanic or Latino	Completed study, Discontinued therapy				2017	0	PIV17	Visit 17/Week 52	2012-01-11	362.0	6.0	10.0	0.478398438	0.52650587	0.390959365	0.422981378	-0.048107432	-0.032022013	0.465520469	0.458364575	0.382210448	0.377315653	0.007155894	0.004894795	0.57	60.0	0.57	60.0	2014-06-06
RETAIN_192151	SUB228871	Visit 21 (Week 104)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-12-30	2010-12-30	-15.0	2010-10-10	-96.0	2011-01-14	Yes	2011-01-14	Yes	Yes	E/I/S	2011-01-14		2011-01-21		2013-01-11	2012-01-11	728.0	Yes	Complete		2013-01-11	728.0					No	2.0	0.0	2011-01-21	7.0	Investigator Decision	16.0	Male		72.0	23.78	Black or African American	Black or African American	Not Hispanic or Latino	Completed study, Discontinued therapy				2021	0	PIV21	Visit 21/Week 104	2013-01-05	722.0	6.0	10.0	0.188773438	0.52650587	0.172922051	0.422981378	-0.337732432	-0.250059328	0.193893594	0.458364575	0.177219894	0.377315653	-0.264470981	-0.20009576	0.23	120.0	0.23	120.0	2014-06-06
RETAIN_215465	SUB228872	Visit -1 (Week -1)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-12-17	2010-12-17	-18.0	2010-10-02	-94.0	2011-01-04	Yes	2011-01-04	Yes	Yes	E/I/S	2011-01-04	2011-03-09	2011-02-08	2011-04-13	2013-01-11	2011-12-28	738.0	Yes	Complete		2013-01-11	738.0					Yes	6.0	6.0	2011-04-18	104.0		9.0	Female	143.8	37.2	17.99	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2010-12-17	-18.0	6.0	10.0	1.13713928	1.13713928	0.75946815	0.75946815			1.212543543	1.212543543	0.794142778	0.794142778			1.64	118.0	1.66	148.0	2014-06-06
RETAIN_215465	SUB228872	Visit 14 (Week 8)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-12-17	2010-12-17	-18.0	2010-10-02	-94.0	2011-01-04	Yes	2011-01-04	Yes	Yes	E/I/S	2011-01-04	2011-03-09	2011-02-08	2011-04-13	2013-01-11	2011-12-28	738.0	Yes	Complete		2013-01-11	738.0					Yes	6.0	6.0	2011-04-18	104.0		9.0	Female	143.8	37.2	17.99	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2011-05-04	120.0	6.0	6.0	1.181813913	1.13713928	0.780156601	0.75946815	0.044674633	0.020688452		1.212543543		0.794142778			1.51	115.0	1.51	115.0	2014-06-06
RETAIN_215465	SUB228872	Visit 15 (Week 19)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-12-17	2010-12-17	-18.0	2010-10-02	-94.0	2011-01-04	Yes	2011-01-04	Yes	Yes	E/I/S	2011-01-04	2011-03-09	2011-02-08	2011-04-13	2013-01-11	2011-12-28	738.0	Yes	Complete		2013-01-11	738.0					Yes	6.0	6.0	2011-04-18	104.0		9.0	Female	143.8	37.2	17.99	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2011-07-22	199.0	6.0	6.0	0.976755966	1.13713928	0.6814571	0.75946815	-0.160383313	-0.078011049		1.212543543		0.794142778			1.51	119.0	1.51	119.0	2014-06-06
RETAIN_215465	SUB228872	Visit 17 (Week 52)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-12-17	2010-12-17	-18.0	2010-10-02	-94.0	2011-01-04	Yes	2011-01-04	Yes	Yes	E/I/S	2011-01-04	2011-03-09	2011-02-08	2011-04-13	2013-01-11	2011-12-28	738.0	Yes	Complete		2013-01-11	738.0					Yes	6.0	6.0	2011-04-18	104.0		9.0	Female	143.8	37.2	17.99	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2011-12-28	358.0	6.0	10.0	0.846808333	1.13713928	0.613458924	0.75946815	-0.290330946	-0.146009226	0.797228165	1.212543543	0.586245569	0.794142778	-0.415315378	-0.207897209	1.0	57.0	1.0	57.0	2014-06-06
RETAIN_215465	SUB228872	Visit 21 (Week 104)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-12-17	2010-12-17	-18.0	2010-10-02	-94.0	2011-01-04	Yes	2011-01-04	Yes	Yes	E/I/S	2011-01-04	2011-03-09	2011-02-08	2011-04-13	2013-01-11	2011-12-28	738.0	Yes	Complete		2013-01-11	738.0					Yes	6.0	6.0	2011-04-18	104.0		9.0	Female	143.8	37.2	17.99	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2013-01-11	738.0	6.0	10.0	0.115543254	1.13713928	0.10934151	0.75946815	-1.021596025	-0.65012664	0.128322108	1.212543543	0.120731669	0.794142778	-1.084221435	-0.673411109	0.17	116.0	0.2	146.0	2014-06-06
RETAIN_300339	SUB228873	Visit -1 (Week -1)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-10-05	2010-10-05	-8.0	2010-09-18	-25.0	2010-10-13	Yes	2010-10-13	Yes	Yes	E/I/S	2010-10-13	2010-12-22	2010-11-17	2011-01-26	2012-10-05	2011-10-15	723.0	Yes	Complete		2012-10-05	723.0					Yes	6.0	6.0	2011-01-26	105.0		13.0	Male		54.0	18.8	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2010-10-05	-8.0	6.0	10.0	0.583495435	0.583495435	0.459634704	0.459634704			0.648936064	0.648936064	0.50013027	0.50013027			0.73	115.0	0.82	175.0	2014-06-06
RETAIN_300339	SUB228873	Visit 14 (Week 8)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-10-05	2010-10-05	-8.0	2010-09-18	-25.0	2010-10-13	Yes	2010-10-13	Yes	Yes	E/I/S	2010-10-13	2010-12-22	2010-11-17	2011-01-26	2012-10-05	2011-10-15	723.0	Yes	Complete		2012-10-05	723.0					Yes	6.0	6.0	2011-01-26	105.0		13.0	Male		54.0	18.8	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2011-02-16	126.0	6.0	6.0	0.572054348	0.583495435	0.452383266	0.459634704	-0.011441087	-0.007251438		0.648936064		0.50013027			0.74	115.0	0.74	115.0	2014-06-06
RETAIN_300339	SUB228873	Visit 15 (Week 19)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-10-05	2010-10-05	-8.0	2010-09-18	-25.0	2010-10-13	Yes	2010-10-13	Yes	Yes	E/I/S	2010-10-13	2010-12-22	2010-11-17	2011-01-26	2012-10-05	2011-10-15	723.0	Yes	Complete		2012-10-05	723.0					Yes	6.0	6.0	2011-01-26	105.0		13.0	Male		54.0	18.8	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2011-05-06	205.0	6.0	6.0	0.324049	0.583495435	0.280694466	0.459634704	-0.259446435	-0.178940238		0.648936064		0.50013027			0.36	25.0	0.36	25.0	2014-06-06
RETAIN_300339	SUB228873	Visit 17 (Week 52)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-10-05	2010-10-05	-8.0	2010-09-18	-25.0	2010-10-13	Yes	2010-10-13	Yes	Yes	E/I/S	2010-10-13	2010-12-22	2010-11-17	2011-01-26	2012-10-05	2011-10-15	723.0	Yes	Complete		2012-10-05	723.0					Yes	6.0	6.0	2011-01-26	105.0		13.0	Male		54.0	18.8	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2011-10-15	367.0	6.0	10.0	0.114924322	0.583495435	0.10878653	0.459634704	-0.468571113	-0.350848174	0.141676345	0.648936064	0.13249766	0.50013027	-0.507259719	-0.36763261	0.18	118.0	0.18	178.0	2014-06-06
RETAIN_300339	SUB228873	Visit 21 (Week 104)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-10-05	2010-10-05	-8.0	2010-09-18	-25.0	2010-10-13	Yes	2010-10-13	Yes	Yes	E/I/S	2010-10-13	2010-12-22	2010-11-17	2011-01-26	2012-10-05	2011-10-15	723.0	Yes	Complete		2012-10-05	723.0					Yes	6.0	6.0	2011-01-26	105.0		13.0	Male		54.0	18.8	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2012-10-05	723.0	6.0	10.0	0.048037076	0.583495435	0.046918963	0.459634704	-0.535458359	-0.412715741	0.050519223	0.648936064	0.04928454	0.50013027	-0.598416841	-0.45084573	0.06	88.0	0.06	88.0	2014-06-06
RETAIN_350507	SUB228874	Visit -1 (Week -1)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-06-15	2010-06-15	-27.0	2010-05-28	-45.0	2010-07-12	Yes	2010-07-12	Yes	Yes	E/I/S	2010-07-12	2010-09-29	2010-08-16	2010-11-03	2012-07-14	2011-07-04	733.0	Yes	Complete		2012-07-14	733.0					Yes	6.0	6.0	2010-11-03	114.0		13.0	Male	163.5	51.6	19.3	White	White	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2010-06-15	-27.0	6.0	10.0	0.808488901	0.808488901	0.592491635	0.592491635			0.904411917	0.904411917	0.644173256	0.644173256			1.07	116.0	1.09	146.0	2014-06-06
RETAIN_350507	SUB228874	Visit 14 (Week 8)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-06-15	2010-06-15	-27.0	2010-05-28	-45.0	2010-07-12	Yes	2010-07-12	Yes	Yes	E/I/S	2010-07-12	2010-09-29	2010-08-16	2010-11-03	2012-07-14	2011-07-04	733.0	Yes	Complete		2012-07-14	733.0					Yes	6.0	6.0	2010-11-03	114.0		13.0	Male	163.5	51.6	19.3	White	White	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2010-11-23	134.0	6.0	6.0	1.438842609	0.808488901	0.891523586	0.592491635	0.630353708	0.299031951		0.904411917		0.644173256			1.63	55.0	1.63	55.0	2014-06-06
RETAIN_350507	SUB228874	Visit 15 (Week 19)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-06-15	2010-06-15	-27.0	2010-05-28	-45.0	2010-07-12	Yes	2010-07-12	Yes	Yes	E/I/S	2010-07-12	2010-09-29	2010-08-16	2010-11-03	2012-07-14	2011-07-04	733.0	Yes	Complete		2012-07-14	733.0					Yes	6.0	6.0	2010-11-03	114.0		13.0	Male	163.5	51.6	19.3	White	White	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2011-02-13	216.0	6.0	6.0	1.746231875	0.808488901	1.010229745	0.592491635	0.937742974	0.41773811		0.904411917		0.644173256			2.14	120.0	2.14	120.0	2014-06-06
RETAIN_350507	SUB228874	Visit 17 (Week 52)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-06-15	2010-06-15	-27.0	2010-05-28	-45.0	2010-07-12	Yes	2010-07-12	Yes	Yes	E/I/S	2010-07-12	2010-09-29	2010-08-16	2010-11-03	2012-07-14	2011-07-04	733.0	Yes	Complete		2012-07-14	733.0					Yes	6.0	6.0	2010-11-03	114.0		13.0	Male	163.5	51.6	19.3	White	White	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2011-07-04	357.0	6.0	10.0	1.384510938	0.808488901	0.868994046	0.592491635	0.576022037	0.276502411	1.405560469	0.904411917	0.87778292	0.644173256	0.501148551	0.233609663	1.49	15.0	1.54	150.0	2014-06-06
RETAIN_350507	SUB228874	Visit 21 (Week 104)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-06-15	2010-06-15	-27.0	2010-05-28	-45.0	2010-07-12	Yes	2010-07-12	Yes	Yes	E/I/S	2010-07-12	2010-09-29	2010-08-16	2010-11-03	2012-07-14	2011-07-04	733.0	Yes	Complete		2012-07-14	733.0					Yes	6.0	6.0	2010-11-03	114.0		13.0	Male	163.5	51.6	19.3	White	White	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2012-07-14	733.0	6.0	10.0	0.507878125	0.808488901	0.410703447	0.592491635	-0.300610776	-0.181788188	0.624272896	0.904411917	0.485060267	0.644173256	-0.280139022	-0.159112989	0.75	120.0	0.76	240.0	2014-06-06
RETAIN_465679	SUB228875	Visit -1 (Week -1)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-06-06	2010-06-06	-20.0	2010-04-27	-60.0	2010-06-26	Yes	2010-06-26	Yes	Yes	E/I/S	2010-06-26	2010-08-28	2010-07-31	2010-10-02	2010-10-24		120.0	No	Terminated early from protocol		2011-02-09	228.0	Failure to Return/Lost to Follow-Up				Yes	6.0	6.0	2010-10-02	98.0		19.0	Male	170.1	67.8	23.43	White	White	Not Hispanic or Latino	Terminated from study				1000	0	PIV-1	Visit -1/Week -1	2010-06-06	-20.0	6.0	10.0	0.671972076	0.671972076	0.514003814	0.514003814			0.848020609	0.848020609	0.614115125	0.614115125			1.22	118.0	1.24	148.0	2014-06-06
RETAIN_465679	SUB228875	Visit 14 (Week 8)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-06-06	2010-06-06	-20.0	2010-04-27	-60.0	2010-06-26	Yes	2010-06-26	Yes	Yes	E/I/S	2010-06-26	2010-08-28	2010-07-31	2010-10-02	2010-10-24		120.0	No	Terminated early from protocol		2011-02-09	228.0	Failure to Return/Lost to Follow-Up				Yes	6.0	6.0	2010-10-02	98.0		19.0	Male	170.1	67.8	23.43	White	White	Not Hispanic or Latino	Terminated from study				2014	0	PIV14	Visit 14/Week 8	2010-10-24	120.0	6.0	6.0	0.973376429	0.671972076	0.679745999	0.514003814	0.301404352	0.165742185		0.848020609		0.614115125			1.37	119.0	1.37	119.0	2014-06-06
RETAIN_511474	SUB228876	Visit -1 (Week -1)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-09-14	2010-09-14	-19.0	2010-09-04	-29.0	2010-10-03	Yes	2010-10-03	Yes	Yes	E/I/S	2010-10-03	2010-12-05	2010-11-07	2011-01-09	2012-09-25	2011-09-25	723.0	Yes	Complete		2012-09-25	723.0					Yes	6.0	6.0	2011-01-09	98.0		33.0	Male	180.0	94.2	29.07	White	White	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2010-09-14	-19.0	6.0	10.0	0.937494916	0.937494916	0.661395858	0.661395858			0.845705	0.845705	0.612861318	0.612861318			1.09	89.0	1.09	89.0	2014-06-06
RETAIN_511474	SUB228876	Visit 14 (Week 8)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-09-14	2010-09-14	-19.0	2010-09-04	-29.0	2010-10-03	Yes	2010-10-03	Yes	Yes	E/I/S	2010-10-03	2010-12-05	2010-11-07	2011-01-09	2012-09-25	2011-09-25	723.0	Yes	Complete		2012-09-25	723.0					Yes	6.0	6.0	2011-01-09	98.0		33.0	Male	180.0	94.2	29.07	White	White	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2011-01-30	119.0	6.0	6.0	0.900083571	0.937494916	0.64189787	0.661395858	-0.037411345	-0.019497988		0.845705		0.612861318			1.24	59.0	1.24	59.0	2014-06-06
RETAIN_511474	SUB228876	Visit 15 (Week 19)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-09-14	2010-09-14	-19.0	2010-09-04	-29.0	2010-10-03	Yes	2010-10-03	Yes	Yes	E/I/S	2010-10-03	2010-12-05	2010-11-07	2011-01-09	2012-09-25	2011-09-25	723.0	Yes	Complete		2012-09-25	723.0					Yes	6.0	6.0	2011-01-09	98.0		33.0	Male	180.0	94.2	29.07	White	White	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2011-04-18	197.0	6.0	6.0	1.196133866	0.937494916	0.786698481	0.661395858	0.25863895	0.125302622		0.845705		0.612861318			1.49	59.0	1.49	59.0	2014-06-06
RETAIN_511474	SUB228876	Visit 17 (Week 52)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-09-14	2010-09-14	-19.0	2010-09-04	-29.0	2010-10-03	Yes	2010-10-03	Yes	Yes	E/I/S	2010-10-03	2010-12-05	2010-11-07	2011-01-09	2012-09-25	2011-09-25	723.0	Yes	Complete		2012-09-25	723.0					Yes	6.0	6.0	2011-01-09	98.0		33.0	Male	180.0	94.2	29.07	White	White	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2011-09-25	357.0	6.0	10.0	1.677001765	0.937494916	0.984697424	0.661395858	0.739506849	0.323301566	1.340425356	0.845705	0.850332689	0.612861318	0.494720356	0.23747137	1.9	59.0	1.9	59.0	2014-06-06
RETAIN_511474	SUB228876	Visit 21 (Week 104)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-09-14	2010-09-14	-19.0	2010-09-04	-29.0	2010-10-03	Yes	2010-10-03	Yes	Yes	E/I/S	2010-10-03	2010-12-05	2010-11-07	2011-01-09	2012-09-25	2011-09-25	723.0	Yes	Complete		2012-09-25	723.0					Yes	6.0	6.0	2011-01-09	98.0		33.0	Male	180.0	94.2	29.07	White	White	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2012-09-25	723.0	6.0	10.0	1.588819244	0.937494916	0.951201882	0.661395858	0.651324328	0.289806023	1.492500934	0.845705	0.913286598	0.612861318	0.646795934	0.300425279	1.74	69.0	1.74	69.0	2014-06-06
RETAIN_516891	SUB228877	Visit -1 (Week -1)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-05-29	2011-05-29	-28.0	2011-04-30	-57.0	2011-06-26	Yes	2011-06-26	Yes	Yes	E/I/S	2011-06-26	2011-09-04	2011-07-31	2011-10-09	2012-11-06	2012-07-25	499.0	No	Terminated early from protocol		2013-02-05	590.0	Failure to Return/Lost to Follow-Up				Yes	6.0	6.0	2011-10-09	105.0		12.0	Male	154.9	43.9	18.3	White	Multiple Races	Not Hispanic or Latino	Terminated from study				1000	0	PIV-1	Visit -1/Week -1	2011-05-29	-28.0	6.0	10.0	0.864197826	0.864197826	0.622830841	0.622830841			0.934405957	0.934405957	0.659800281	0.659800281			1.04	55.0	1.09	175.0	2014-06-06
RETAIN_516891	SUB228877	Visit 14 (Week 8)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-05-29	2011-05-29	-28.0	2011-04-30	-57.0	2011-06-26	Yes	2011-06-26	Yes	Yes	E/I/S	2011-06-26	2011-09-04	2011-07-31	2011-10-09	2012-11-06	2012-07-25	499.0	No	Terminated early from protocol		2013-02-05	590.0	Failure to Return/Lost to Follow-Up				Yes	6.0	6.0	2011-10-09	105.0		12.0	Male	154.9	43.9	18.3	White	Multiple Races	Not Hispanic or Latino	Terminated from study				2014	0	PIV14	Visit 14/Week 8	2011-10-30	126.0	6.0	6.0	0.635575167	0.864197826	0.491994526	0.622830841	-0.228622659	-0.130836314		0.934405957		0.659800281			0.77	30.0	0.77	30.0	2014-06-06
RETAIN_516891	SUB228877	Visit 15 (Week 19)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-05-29	2011-05-29	-28.0	2011-04-30	-57.0	2011-06-26	Yes	2011-06-26	Yes	Yes	E/I/S	2011-06-26	2011-09-04	2011-07-31	2011-10-09	2012-11-06	2012-07-25	499.0	No	Terminated early from protocol		2013-02-05	590.0	Failure to Return/Lost to Follow-Up				Yes	6.0	6.0	2011-10-09	105.0		12.0	Male	154.9	43.9	18.3	White	Multiple Races	Not Hispanic or Latino	Terminated from study				2015	0	PIV15	Visit 15/Week 19	2012-01-17	205.0	6.0	6.0	0.433015897	0.864197826	0.359781243	0.622830841	-0.431181929	-0.263049598		0.934405957		0.659800281			0.58	117.0	0.58	117.0	2014-06-06
RETAIN_516891	SUB228877	Visit 17 (Week 52)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-05-29	2011-05-29	-28.0	2011-04-30	-57.0	2011-06-26	Yes	2011-06-26	Yes	Yes	E/I/S	2011-06-26	2011-09-04	2011-07-31	2011-10-09	2012-11-06	2012-07-25	499.0	No	Terminated early from protocol		2013-02-05	590.0	Failure to Return/Lost to Follow-Up				Yes	6.0	6.0	2011-10-09	105.0		12.0	Male	154.9	43.9	18.3	White	Multiple Races	Not Hispanic or Latino	Terminated from study				2017	0	PIV17	Visit 17/Week 52	2012-07-25	395.0	6.0	10.0	0.07902625	0.864197826	0.076059014	0.622830841	-0.785171576	-0.546771826	0.083784375	0.934405957	0.080458967	0.659800281	-0.850621582	-0.579341313	0.1	120.0	0.1	120.0	2014-06-06
RETAIN_615116	SUB228878	Visit -1 (Week -1)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-11-29	2010-11-29	-19.0	2010-09-10	-99.0	2010-12-18	Yes	2010-12-18	Yes	Yes	E/I/S	2010-12-18	2011-03-12	2011-01-22	2011-04-16	2012-12-11	2011-12-13	724.0	Yes	Complete		2012-12-11	724.0					Yes	5.0	6.0	2011-04-16	119.0		13.0	Male	155.3	40.8	16.92	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2010-11-29	-19.0	6.0	10.0	0.623004063	0.623004063	0.484278792	0.484278792			0.624090156	0.624090156	0.484947755	0.484947755			0.77	90.0	0.77	90.0	2014-06-06
RETAIN_615116	SUB228878	Visit 14 (Week 8)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-11-29	2010-11-29	-19.0	2010-09-10	-99.0	2010-12-18	Yes	2010-12-18	Yes	Yes	E/I/S	2010-12-18	2011-03-12	2011-01-22	2011-04-16	2012-12-11	2011-12-13	724.0	Yes	Complete		2012-12-11	724.0					Yes	5.0	6.0	2011-04-16	119.0		13.0	Male	155.3	40.8	16.92	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2011-05-07	140.0	6.0	6.0	0.3847875	0.623004063	0.325546698	0.484278792	-0.238216563	-0.158732093		0.624090156		0.484947755			0.44	120.0	0.44	120.0	2014-06-06
RETAIN_615116	SUB228878	Visit 15 (Week 19)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-11-29	2010-11-29	-19.0	2010-09-10	-99.0	2010-12-18	Yes	2010-12-18	Yes	Yes	E/I/S	2010-12-18	2011-03-12	2011-01-22	2011-04-16	2012-12-11	2011-12-13	724.0	Yes	Complete		2012-12-11	724.0					Yes	5.0	6.0	2011-04-16	119.0		13.0	Male	155.3	40.8	16.92	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2011-07-25	219.0	6.0	6.0	0.516153125	0.623004063	0.416176288	0.484278792	-0.106850937	-0.068102504		0.624090156		0.484947755			0.71	120.0	0.71	120.0	2014-06-06
RETAIN_615116	SUB228878	Visit 17 (Week 52)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-11-29	2010-11-29	-19.0	2010-09-10	-99.0	2010-12-18	Yes	2010-12-18	Yes	Yes	E/I/S	2010-12-18	2011-03-12	2011-01-22	2011-04-16	2012-12-11	2011-12-13	724.0	Yes	Complete		2012-12-11	724.0					Yes	5.0	6.0	2011-04-16	119.0		13.0	Male	155.3	40.8	16.92	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2011-12-13	360.0	6.0	10.0	0.512119063	0.623004063	0.41351202	0.484278792	-0.110885	-0.070766772	0.544650156	0.624090156	0.434797449	0.484947755	-0.07944	-0.050150307	0.57	120.0	0.61	150.0	2014-06-06
RETAIN_615116	SUB228878	Visit 21 (Week 104)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2010-11-29	2010-11-29	-19.0	2010-09-10	-99.0	2010-12-18	Yes	2010-12-18	Yes	Yes	E/I/S	2010-12-18	2011-03-12	2011-01-22	2011-04-16	2012-12-11	2011-12-13	724.0	Yes	Complete		2012-12-11	724.0					Yes	5.0	6.0	2011-04-16	119.0		13.0	Male	155.3	40.8	16.92	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2012-12-11	724.0	6.0	10.0	0.23956125	0.623004063	0.214757486	0.484278792	-0.383442812	-0.269521305	0.2474225	0.624090156	0.221079423	0.484947755	-0.376667656	-0.263868333	0.29	120.0	0.29	120.0	2014-06-06
RETAIN_703798	SUB228879	Visit -1 (Week -1)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-03-14	2010-03-18	-9.0	2009-12-18	-99.0	2010-03-27	Yes	2010-03-27	Yes	Yes	E/I/S	2010-03-27	2010-05-29	2010-05-01	2010-07-03	2012-03-31	2011-03-25	735.0	Yes	Complete		2012-03-31	735.0					Yes	6.0	6.0	2010-07-03	98.0		17.0	Female	165.1	51.8	19.0	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2010-03-18	-9.0	6.0	10.0	0.527841563	0.527841563	0.423855996	0.423855996			0.562027656	0.562027656	0.445984757	0.445984757			0.68	120.0	0.7	150.0	2014-06-06
RETAIN_703798	SUB228879	Visit 14 (Week 8)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-03-14	2010-03-18	-9.0	2009-12-18	-99.0	2010-03-27	Yes	2010-03-27	Yes	Yes	E/I/S	2010-03-27	2010-05-29	2010-05-01	2010-07-03	2012-03-31	2011-03-25	735.0	Yes	Complete		2012-03-31	735.0					Yes	6.0	6.0	2010-07-03	98.0		17.0	Female	165.1	51.8	19.0	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2010-07-24	119.0	6.0	6.0	0.511705313	0.527841563	0.41323836	0.423855996	-0.01613625	-0.010617636		0.562027656		0.445984757			0.71	120.0	0.71	120.0	2014-06-06
RETAIN_703798	SUB228879	Visit 15 (Week 19)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-03-14	2010-03-18	-9.0	2009-12-18	-99.0	2010-03-27	Yes	2010-03-27	Yes	Yes	E/I/S	2010-03-27	2010-05-29	2010-05-01	2010-07-03	2012-03-31	2011-03-25	735.0	Yes	Complete		2012-03-31	735.0					Yes	6.0	6.0	2010-07-03	98.0		17.0	Female	165.1	51.8	19.0	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2010-10-10	197.0	6.0	6.0	0.292004063	0.527841563	0.25619455	0.423855996	-0.2358375	-0.167661446		0.562027656		0.445984757			0.33	90.0	0.33	90.0	2014-06-06
RETAIN_703798	SUB228879	Visit 17 (Week 52)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-03-14	2010-03-18	-9.0	2009-12-18	-99.0	2010-03-27	Yes	2010-03-27	Yes	Yes	E/I/S	2010-03-27	2010-05-29	2010-05-01	2010-07-03	2012-03-31	2011-03-25	735.0	Yes	Complete		2012-03-31	735.0					Yes	6.0	6.0	2010-07-03	98.0		17.0	Female	165.1	51.8	19.0	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2011-03-25	363.0	6.0	10.0	0.17543	0.527841563	0.161634038	0.423855996	-0.352411563	-0.262221958	0.203358125	0.562027656	0.185116086	0.445984757	-0.358669531	-0.260868671	0.28	120.0	0.28	120.0	2014-06-06
RETAIN_703798	SUB228879	Visit 21 (Week 104)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-03-14	2010-03-18	-9.0	2009-12-18	-99.0	2010-03-27	Yes	2010-03-27	Yes	Yes	E/I/S	2010-03-27	2010-05-29	2010-05-01	2010-07-03	2012-03-31	2011-03-25	735.0	Yes	Complete		2012-03-31	735.0					Yes	6.0	6.0	2010-07-03	98.0		17.0	Female	165.1	51.8	19.0	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2012-03-31	735.0	6.0	10.0	0.090404375	0.527841563	0.086548614	0.423855996	-0.437437188	-0.337307382	0.120090938	0.562027656	0.113409876	0.445984757	-0.441936719	-0.332574881	0.15	120.0	0.17	180.0	2014-06-06
RETAIN_731341	SUB228880	Visit -1 (Week -1)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-08-15	2010-08-15	-35.0	2010-06-09	-102.0	2010-09-19	Yes	2010-09-19	Yes	Yes	E/I/S	2010-09-19	2010-11-21	2010-10-24	2010-12-26	2012-10-06	2011-09-22	748.0	Yes	Complete		2012-10-06	748.0					Yes	6.0	6.0	2010-12-26	98.0		18.0	Male	174.2	69.3	22.84	White	White	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2010-08-15	-35.0	6.0	10.0	1.377885678	1.377885678	0.866211722	0.866211722			1.520736387	1.520736387	0.924551076	0.924551076			1.95	118.0	1.95	118.0	2014-06-06
RETAIN_731341	SUB228880	Visit 14 (Week 8)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-08-15	2010-08-15	-35.0	2010-06-09	-102.0	2010-09-19	Yes	2010-09-19	Yes	Yes	E/I/S	2010-09-19	2010-11-21	2010-10-24	2010-12-26	2012-10-06	2011-09-22	748.0	Yes	Complete		2012-10-06	748.0					Yes	6.0	6.0	2010-12-26	98.0		18.0	Male	174.2	69.3	22.84	White	White	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2011-01-16	119.0	6.0	6.0	0.791125064	1.377885678	0.58284395	0.866211722	-0.586760614	-0.283367773		1.520736387		0.924551076			1.57	118.0	1.57	118.0	2014-06-06
RETAIN_731341	SUB228880	Visit 15 (Week 19)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-08-15	2010-08-15	-35.0	2010-06-09	-102.0	2010-09-19	Yes	2010-09-19	Yes	Yes	E/I/S	2010-09-19	2010-11-21	2010-10-24	2010-12-26	2012-10-06	2011-09-22	748.0	Yes	Complete		2012-10-06	748.0					Yes	6.0	6.0	2010-12-26	98.0		18.0	Male	174.2	69.3	22.84	White	White	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2011-04-08	201.0	6.0	6.0	0.92969625	1.377885678	0.657362607	0.866211722	-0.448189428	-0.208849115		1.520736387		0.924551076			1.19	120.0	1.19	120.0	2014-06-06
RETAIN_731341	SUB228880	Visit 17 (Week 52)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-08-15	2010-08-15	-35.0	2010-06-09	-102.0	2010-09-19	Yes	2010-09-19	Yes	Yes	E/I/S	2010-09-19	2010-11-21	2010-10-24	2010-12-26	2012-10-06	2011-09-22	748.0	Yes	Complete		2012-10-06	748.0					Yes	6.0	6.0	2010-12-26	98.0		18.0	Male	174.2	69.3	22.84	White	White	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2011-09-22	368.0	6.0	10.0	0.842492353	1.377885678	0.611119195	0.866211722	-0.535393325	-0.255092528	0.911828829	1.520736387	0.648060286	0.924551076	-0.608907558	-0.27649079	0.98	119.0	1.05	149.0	2014-06-06
RETAIN_731341	SUB228880	Visit 21 (Week 104)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-08-15	2010-08-15	-35.0	2010-06-09	-102.0	2010-09-19	Yes	2010-09-19	Yes	Yes	E/I/S	2010-09-19	2010-11-21	2010-10-24	2010-12-26	2012-10-06	2011-09-22	748.0	Yes	Complete		2012-10-06	748.0					Yes	6.0	6.0	2010-12-26	98.0		18.0	Male	174.2	69.3	22.84	White	White	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2012-10-06	748.0	6.0	10.0	0.218395797	1.377885678	0.197535073	0.866211722	-1.159489881	-0.668676649	0.251879078	1.520736387	0.224645685	0.924551076	-1.268857308	-0.69990539	0.24	116.0	0.32	236.0	2014-06-06
RETAIN_775379	SUB228881	Visit -1 (Week -1)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-09-04	2010-09-04	-28.0	2010-08-10	-53.0	2010-10-02	Yes	2010-10-02	Yes	Yes	E/I/S	2010-10-02	2010-12-04	2010-11-06	2011-01-08	2012-10-02	2011-10-03	731.0	Yes	Complete		2012-10-02	731.0					Yes	6.0	6.0	2011-01-08	98.0		23.0	Male	175.5	84.3	27.37	White	White	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2010-09-04	-28.0	6.0	10.0	0.094128125	0.094128125	0.089957813	0.089957813			0.118849688	0.118849688	0.112301093	0.112301093			0.13	120.0	0.16	210.0	2014-06-06
RETAIN_775379	SUB228881	Visit 14 (Week 8)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-09-04	2010-09-04	-28.0	2010-08-10	-53.0	2010-10-02	Yes	2010-10-02	Yes	Yes	E/I/S	2010-10-02	2010-12-04	2010-11-06	2011-01-08	2012-10-02	2011-10-03	731.0	Yes	Complete		2012-10-02	731.0					Yes	6.0	6.0	2011-01-08	98.0		23.0	Male	175.5	84.3	27.37	White	White	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2011-01-29	119.0	6.0	6.0	0.383140234	0.094128125	0.324356446	0.089957813	0.289012109	0.234398633		0.118849688		0.112301093			0.56	107.0	0.56	107.0	2014-06-06
RETAIN_775379	SUB228881	Visit 15 (Week 19)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-09-04	2010-09-04	-28.0	2010-08-10	-53.0	2010-10-02	Yes	2010-10-02	Yes	Yes	E/I/S	2010-10-02	2010-12-04	2010-11-06	2011-01-08	2012-10-02	2011-10-03	731.0	Yes	Complete		2012-10-02	731.0					Yes	6.0	6.0	2011-01-08	98.0		23.0	Male	175.5	84.3	27.37	White	White	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2011-04-13	193.0	6.0	6.0	0.34583937	0.094128125	0.297017885	0.089957813	0.251711245	0.207060072		0.118849688		0.112301093			0.49	119.0	0.49	119.0	2014-06-06
RETAIN_775379	SUB228881	Visit 17 (Week 52)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-09-04	2010-09-04	-28.0	2010-08-10	-53.0	2010-10-02	Yes	2010-10-02	Yes	Yes	E/I/S	2010-10-02	2010-12-04	2010-11-06	2011-01-08	2012-10-02	2011-10-03	731.0	Yes	Complete		2012-10-02	731.0					Yes	6.0	6.0	2011-01-08	98.0		23.0	Male	175.5	84.3	27.37	White	White	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2011-10-03	366.0	6.0	10.0	0.110155678	0.094128125	0.104500256	0.089957813	0.016027553	0.014542443	0.125752185	0.118849688	0.118451421	0.112301093	0.006902497	0.006150328	0.18	118.0	0.18	118.0	2014-06-06
RETAIN_775379	SUB228881	Visit 21 (Week 104)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2010-09-04	2010-09-04	-28.0	2010-08-10	-53.0	2010-10-02	Yes	2010-10-02	Yes	Yes	E/I/S	2010-10-02	2010-12-04	2010-11-06	2011-01-08	2012-10-02	2011-10-03	731.0	Yes	Complete		2012-10-02	731.0					Yes	6.0	6.0	2011-01-08	98.0		23.0	Male	175.5	84.3	27.37	White	White	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2012-10-02	731.0	6.0	10.0	0.118005672	0.094128125	0.111546448	0.089957813	0.023877547	0.021588635	0.135204498	0.118849688	0.126812809	0.112301093	0.01635481	0.014511716	0.16	89.0	0.18	149.0	2014-06-06
RETAIN_820343	SUB228882	Visit -1 (Week -1)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-03-12	2011-03-12	-16.0	2011-03-08	-20.0	2011-03-28	Yes	2011-03-28	Yes	Yes	E/I/S	2011-03-28	2011-06-27	2011-05-02	2011-08-01	2013-04-02	2012-03-19	736.0	Yes	Complete		2013-04-02	736.0					Yes	6.0	6.0	2011-08-01	126.0		8.0	Female	144.5	55.5	26.58	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				1000	0	PIV-1	Visit -1/Week -1	2011-03-12	-16.0	6.0	10.0	0.992471513	0.992471513	0.689375834	0.689375834			0.980480167	0.980480167	0.683339324	0.683339324			1.22	119.0	1.22	119.0	2014-06-06
RETAIN_820343	SUB228882	Visit 14 (Week 8)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-03-12	2011-03-12	-16.0	2011-03-08	-20.0	2011-03-28	Yes	2011-03-28	Yes	Yes	E/I/S	2011-03-28	2011-06-27	2011-05-02	2011-08-01	2013-04-02	2012-03-19	736.0	Yes	Complete		2013-04-02	736.0					Yes	6.0	6.0	2011-08-01	126.0		8.0	Female	144.5	55.5	26.58	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2014	0	PIV14	Visit 14/Week 8	2011-08-22	147.0	6.0	6.0	0.939288992	0.992471513	0.662321407	0.689375834	-0.053182521	-0.027054428		0.980480167		0.683339324			1.19	119.0	1.19	119.0	2014-06-06
RETAIN_820343	SUB228882	Visit 15 (Week 19)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-03-12	2011-03-12	-16.0	2011-03-08	-20.0	2011-03-28	Yes	2011-03-28	Yes	Yes	E/I/S	2011-03-28	2011-06-27	2011-05-02	2011-08-01	2013-04-02	2012-03-19	736.0	Yes	Complete		2013-04-02	736.0					Yes	6.0	6.0	2011-08-01	126.0		8.0	Female	144.5	55.5	26.58	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2015	0	PIV15	Visit 15/Week 19	2011-11-07	224.0	6.0	6.0	0.902698193	0.992471513	0.643272981	0.689375834	-0.089773319	-0.046102854		0.980480167		0.683339324			1.17	89.0	1.17	89.0	2014-06-06
RETAIN_820343	SUB228882	Visit 17 (Week 52)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-03-12	2011-03-12	-16.0	2011-03-08	-20.0	2011-03-28	Yes	2011-03-28	Yes	Yes	E/I/S	2011-03-28	2011-06-27	2011-05-02	2011-08-01	2013-04-02	2012-03-19	736.0	Yes	Complete		2013-04-02	736.0					Yes	6.0	6.0	2011-08-01	126.0		8.0	Female	144.5	55.5	26.58	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2017	0	PIV17	Visit 17/Week 52	2012-03-19	357.0	6.0	10.0	0.973543319	0.992471513	0.679830566	0.689375834	-0.018928193	-0.009545268	1.087390398	0.980480167	0.735914672	0.683339324	0.10691023	0.052575348	1.22	89.0	1.34	179.0	2014-06-06
RETAIN_820343	SUB228882	Visit 21 (Week 104)	ITN041AI	Part 1a	Pediatric	Alpha-1 Antitrypsin	2011-03-12	2011-03-12	-16.0	2011-03-08	-20.0	2011-03-28	Yes	2011-03-28	Yes	Yes	E/I/S	2011-03-28	2011-06-27	2011-05-02	2011-08-01	2013-04-02	2012-03-19	736.0	Yes	Complete		2013-04-02	736.0					Yes	6.0	6.0	2011-08-01	126.0		8.0	Female	144.5	55.5	26.58	White	Multiple Races	Not Hispanic or Latino	Completed study and therapy				2021	0	PIV21	Visit 21/Week 104	2013-04-02	736.0	6.0	10.0	0.916647479	0.992471513	0.650577555	0.689375834	-0.075824034	-0.038798279	0.974511088	0.980480167	0.680320817	0.683339324	-0.005969079	-0.003018507	1.17	89.0	1.17	89.0	2014-06-06
RETAIN_859067	SUB228883	Visit -1 (Week -1)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2011-03-01	2011-03-01	-14.0	2010-12-14	-91.0	2011-03-15	Yes	2011-03-15	Yes	Yes	E/I/S	2011-03-15	2011-05-17	2011-04-19	2011-06-21	2012-06-12	2012-03-13	455.0	No	Terminated early from protocol		2013-03-19	735.0	Failure to Return/Lost to Follow-Up				Yes	6.0	6.0	2011-06-21	98.0		23.0	Female	160.5	48.0	18.63	White	Multiple Races	Unknown	Terminated from study				1000	0	PIV-1	Visit -1/Week -1	2011-03-01	-14.0	6.0	10.0	0.535834301	0.535834301	0.429073752	0.429073752			0.610295158	0.610295158	0.47641749	0.47641749			0.75	118.0	0.75	118.0	2014-06-06
RETAIN_859067	SUB228883	Visit 14 (Week 8)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2011-03-01	2011-03-01	-14.0	2010-12-14	-91.0	2011-03-15	Yes	2011-03-15	Yes	Yes	E/I/S	2011-03-15	2011-05-17	2011-04-19	2011-06-21	2012-06-12	2012-03-13	455.0	No	Terminated early from protocol		2013-03-19	735.0	Failure to Return/Lost to Follow-Up				Yes	6.0	6.0	2011-06-21	98.0		23.0	Female	160.5	48.0	18.63	White	Multiple Races	Unknown	Terminated from study				2014	0	PIV14	Visit 14/Week 8	2011-07-12	119.0	6.0	6.0	0.463193125	0.535834301	0.38062112	0.429073752	-0.072641176	-0.048452632		0.610295158		0.47641749			0.7	120.0	0.7	120.0	2014-06-06
RETAIN_859067	SUB228883	Visit 15 (Week 19)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2011-03-01	2011-03-01	-14.0	2010-12-14	-91.0	2011-03-15	Yes	2011-03-15	Yes	Yes	E/I/S	2011-03-15	2011-05-17	2011-04-19	2011-06-21	2012-06-12	2012-03-13	455.0	No	Terminated early from protocol		2013-03-19	735.0	Failure to Return/Lost to Follow-Up				Yes	6.0	6.0	2011-06-21	98.0		23.0	Female	160.5	48.0	18.63	White	Multiple Races	Unknown	Terminated from study				2015	0	PIV15	Visit 15/Week 19	2011-09-27	196.0	6.0	6.0	0.513272521	0.535834301	0.414274538	0.429073752	-0.02256178	-0.014799214		0.610295158		0.47641749			0.73	119.0	0.73	119.0	2014-06-06
RETAIN_859067	SUB228883	Visit 17 (Week 52)	ITN041AI	Part 1a	Adult	Alpha-1 Antitrypsin	2011-03-01	2011-03-01	-14.0	2010-12-14	-91.0	2011-03-15	Yes	2011-03-15	Yes	Yes	E/I/S	2011-03-15	2011-05-17	2011-04-19	2011-06-21	2012-06-12	2012-03-13	455.0	No	Terminated early from protocol		2013-03-19	735.0	Failure to Return/Lost to Follow-Up				Yes	6.0	6.0	2011-06-21	98.0		23.0	Female	160.5	48.0	18.63	White	Multiple Races	Unknown	Terminated from study				2017	0	PIV17	Visit 17/Week 52	2012-03-13	364.0	6.0	10.0	0.428504746	0.535834301	0.356628265	0.429073752	-0.107329555	-0.072445487	0.459033025	0.610295158	0.377773905	0.47641749	-0.151262132	-0.098643585	0.55	88.0	0.55	88.0	2014-06-06
